Leuprorelin acetate 3.75mg (1 month) & 22.5mg (3 months)

Products

Information

Presentation: 1 vial with powder + 1 PFS with solvent + 1 transfer device Indications for Leuprorelin 3.7mg:Prostate cancer Breast cancer Endometriosis Uterine fibroids Ovarian protection Central Precocious Puberty Indications for Leuprorelin 3.7mg: Prostate cancer
All Categories
Antineoplastics and Immunomodulating Agents
Main Categories
Anatomical Therapeutic Chemical (ATC) Classification Products
Supplied From
Spain
GP Pharm S.A.UGP Pharm is a privately owned pharmaceutical company focused on the development and manufacturing of peptide-based injectable products and specialized in sustained-release systems (i.e. microspheres and liposomes). Vertically integrated, GP manages drug development from R&D to market. GP Pharm operates internationally, marketing via its own network in Spain (B2C) and in more than 40 countries via its global partners (B2B - out licensing). Being widely GMP-approved, GP Pharm offers its expertise to provide third-party companies with CDMO services.

Log in

See all the content and easy-to-use features by logging in or registering!